Horizon Pharma | HZNP - Cost Of Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Horizon Pharma

Horizon Pharma reported $208.56M in Cost of Sales for its fiscal quarter ending in March of 2023.


Cost Of Sales Change
AbbVie ABBV:US USD 3.97B 200M
ALKERMES ALKS:US USD 58.18M 4.21M
Amgen AMGN:US USD 1.68B 65M
AstraZeneca AZN:LN USD 2.05B 458M
Bausch Health Companies Inc VRX:CN USD 582M 70M
Bristol-Myers Squibb BMY:US USD 2.56B 45M
Cara Therapeutics CARA:US USD 2.59M 460K
Coherus Biosciences CHRS:US USD 16.87M 2.67M
Eli Lilly LLY:US USD 1.63B 78.6M
Endo International ENDP:US USD 167.44M 51.37M
Horizon Pharma HZNP:US USD 208.56M 32.22M
Merck & Co MRK:US USD 3.35B 491M
Novartis NOVN:VX USD 3.83B 8M
Pacira PCRX:US USD 49.02M 12.9M
Perrigo PRGO:US USD 767.9M 4.8M
Pfizer PFE:US USD 5.03B 4.8B
Prestige Brands PBH:US USD 132.1M 6.98M
Revance Therapeutics RVNC:US USD 16.17M 7.34M
Supernus Pharmaceuticals SUPN:US USD 23.46M 506K
Takeda 4502:JP JPY 309.77B 26.2B
Xeris Pharmaceuticals Inc XERS:US USD 5.32M 972K
Zoetis ZTS:US USD 554M 97M